Mycobutin

In the US, Mycobutin (rifabutin systemic) is a member of the drug class rifamycin derivatives and is used to treat Mycobacterium avium-intracellulare - Prophylaxis, Mycobacterium avium-intracellulare - Treatment, Tuberculosis - HIV Positive and Tuberculosis - Prophylaxis.

US matches:

• Mycobutin

UK matches:

• Mycobutin (SPC)

Ingredient matches for Mycobutin

Rifabutin

Rifabutin is reported as an ingredient of Mycobutin in the following countries:

• Australia


• Austria


• Belgium


• Canada


• Czech Republic


• Hong Kong


• Israel


• Italy


• Luxembourg


• Netherlands


• New Zealand


• Portugal


• Romania


• South Africa


• Switzerland


• Taiwan


• Turkey


• United Kingdom


• United States

Rifampicin

Rifampicin is reported as an ingredient of Mycobutin in the following countries:

• Greece

International Drug Name Search

Glossary

SPC	Summary of Product Characteristics (UK)

Click for further information on drug naming conventions and International Nonproprietary Names.